ScreenerHero

MEDCL MedinCell S.A.

EPA · FR · Healthcare · Biotechnology · medincell.com
23.06EUR+3.87%Mkt Cap: 900.40M $P/E: —

MedinCell S.A. engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France. Th…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap900.40M USD
Enterprise Value852.53M USD
Revenue (TTM)26.39M USD
Gross Profit21.22M USD
Net Income (TTM)-34.01M USD
Revenue/Share0.73 EUR
Last Price23.06 EUR
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees141
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0004065605
Valuation
P/E (Trailing)—
P/E (Forward)52.86
PEG—
EV/EBITDA-39.14
EV/Revenue32.31
P/S32.85
P/B261.18
EPS (TTM)-0.94
EPS (Forward)0.42
52W Range
19.6917% of range39.68
52W High39.68 EUR
52W Low19.69 EUR
Profitability
Gross Margin100.00%
Oper. Margin-139.50%
EBITDA Margin-82.54%
Profit Margin-160.27%
ROE-1021.12%
ROA-28.95%
Growth
Revenue Growth-44.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.69M USD
CapEx (TTM)2.22M USD
FCF Margin-81.49%
FCF Yield-2.39%
Net Debt-14.03M USD
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity18.74
Current Ratio4.67
Quick Ratio4.59
Book Value/Sh0.09 EUR
Cash/Share2.36 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)34.51 EUR
Upside (mean)+49.7%
Target Range30.00 EUR – 39.00 EUR
30.00+49.7% to mean39.00
# Analysts9
Ownership
Shares Out.35.92M
Float32.79M
Insiders33.98%
Institutions32.22%
Technical
SMA 5023.80 (-3.1%)
SMA 20024.75 (-6.8%)
Beta0.97
S&P 52W Chg14.58%
Avg Vol (30d)68.99K
Avg Vol (10d)75.36K
Technical Indicators
RSI (14)49.3
MACD-0.1148
MACD Signal-0.2518
MACD Hist.+0.1370
BB Upper24.26 EUR
BB Middle22.57 EUR
BB Lower20.87 EUR
BB Width15.01%
ATR (14)0.9292 EUR
Vol Ratio (20d)0.97x